No Picture
News

Berkeley Lights Expands Its Platform and Introduces the OptoSeq(TM) 3′ mRNA Library Kit

The OptoSeq 3′ mRNA Library Kit allows users of Berkeley Lights’ platform to efficiently prepare cells of interest for genomic sequencing opening the door to directly link phenotype to genotype using a single system.

EMERYVILLE, Calif., March 31, 202… […]

No Picture
News

Just in time to assure a decision before CVR deadline, Bristol Myers Squibb files NDA for Celgene CAR-T

A new CAR-T therapy may be coming. And maybe $9 per share for Celgene investors, too.
Bristol Myers Squibb announced they submitted an NDA for the multiple myeloma ?ide-cel? CAR-T therapy Celgene developed in partnership with bluebird. The therapy is o… […]

No Picture
News

Can a pair of top AveXis alumni steer a new gene therapy upstart to R&D glory? 3 VCs bet $60M on it

Rick Modi
VCs love few things more than a proven executive team when it comes to launching a new company. And now a group of A-listers has turned to a pair of top execs out of AveXis to steer the latest gene therapy player into the clinic.
The biotech … […]

No Picture
News

Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology

?– Novel approach to creating Wnt-mimetics establishes proof-of-concept?for targeted regenerative antibodies — SOUTH SAN FRANCISCO, Calif., March 30, 2020 (GLOBE NEWSWIRE) — Surrozen Inc., a biotechnology company pioneering a new class of targeted… […]